Following predictions that a new generation of weight-loss drugs will hurt sales of food and drink, billionaire and Ozempic patient Elon Musk took to his social media platform to share his view on medication’s ability to suppress appetite.
“Our poor limbic system has to fight off the combined effort of billions of humans honing the tastiness of food for thousands of years!” he said on X, formerly known as Twitter.
Analysts have warned that the extraordinary growth outlook for drugs such as Novo Nordisk’s Wegovy and Ozempic, which is prescribed for diabetes but commonly used for weight loss, could hit sales of packaged food and drinks as patients reduce their calorie intake.
您已閱讀11%（682字），剩余89%（5539字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。